Anika Therapeutics reported $1.25M in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -98.58M 14.32M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.44M
Immunogen IMGN:US $ -24.14M 13.03M
Intrexon XON:US $ -29.88M 9.76M
Peregrine Pharmaceuticals PPHM:US $ 3.52M 2.78M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M